ACADIA Pharmaceuticals Inc(NASDAQ:ACAD) 
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associ...
Website: http://www.acadia-pharm.com
Founded: 1993
Full Time Employees: 580
CEO: Catherine Owen Adams
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-05-07
P
O 14.66
H 14.84
L 14.45
C 14.81
V 2,760,844
10EMA 14.81
20EMA 14.81
60EMA 14.81
120EMA 14.81
250EMA 14.81